theory clinical_47_10
imports Main

begin

typedecl entity
typedecl event

consts
  PARPInhibitors :: "entity ⇒ bool"
  PARP :: "entity ⇒ bool"
  DSBs :: "entity ⇒ bool"
  SSBreakRepair :: "entity ⇒ bool"
  Function :: "event ⇒ bool"
  Inhibit :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Cause :: "event ⇒ bool"
  Prevent :: "event ⇒ bool"
  Lead :: "event ⇒ bool"
  To :: "event ⇒ entity ⇒ bool"
  CollapsedReplicationForks :: "entity ⇒ bool"
  RelianceOnNHEJ :: "entity ⇒ bool"
  LossOfBRCA2 :: "entity ⇒ bool"
  CancerDevelopment :: "entity ⇒ bool"
  GenomicInstability :: "entity ⇒ bool"
  Drive :: "event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  Involve :: "event ⇒ bool"
  HRR :: "entity ⇒ bool"
  TrappingOfPARP1 :: "entity ⇒ bool"
  NHEJ :: "entity ⇒ bool"
  Increase :: "event ⇒ bool"
  Toxicity :: "entity ⇒ bool"
  Indicate :: "event ⇒ bool"
  RelianceOn :: "event ⇒ entity ⇒ bool"
  InhibitionOfPARP :: "entity ⇒ bool"
  Contribute :: "event ⇒ bool"
  Rely :: "event ⇒ bool"
  On :: "event ⇒ entity ⇒ bool"

(* Explanation 1: PARP inhibitors function by inhibiting PARP, which directly causes double-strand breaks and prevents single-strand break repair, leading to collapsed replication forks and reliance on error-prone non-homologous end joining for DNA repair. *)
axiomatization where
  explanation_1: "∃x y z w v1 v2 e1 e2 e3 e4 e5. PARPInhibitors x ∧ PARP y ∧ DSBs z ∧ SSBreakRepair w ∧ Function e1 ∧ Agent e1 x ∧ Inhibit e2 ∧ Agent e2 x ∧ Patient e2 y ∧ Cause e3 ∧ Agent e3 x ∧ Patient e3 z ∧ Prevent e4 ∧ Agent e4 x ∧ Patient e4 w ∧ Lead e5 ∧ Agent e5 x ∧ To e5 v1 ∧ CollapsedReplicationForks v1 ∧ To e5 v2 ∧ RelianceOnNHEJ v2"

(* Explanation 2: Loss of BRCA2 drives cancer development via genomic instability, which involves defective homologous recombination repair. *)
axiomatization where
  explanation_2: "∃x y z v e1 e2. LossOfBRCA2 x ∧ CancerDevelopment y ∧ GenomicInstability z ∧ Drive e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Via e1 z ∧ Involve e2 ∧ Agent e2 z ∧ Patient e2 v ∧ HRR v"

(* Explanation 3: Trapping of PARP1 at sites of double-strand breaks increases non-homologous end joining and increases toxicity, indicating reliance on error-prone non-homologous end joining for DNA repair. *)
axiomatization where
  explanation_3: "∃x y z v e1 e2 e3. TrappingOfPARP1 x ∧ DSBs y ∧ NHEJ z ∧ Increase e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Increase e2 ∧ Agent e2 x ∧ Patient e2 v ∧ Toxicity v ∧ Indicate e3 ∧ Agent e3 x ∧ RelianceOn e3 v ∧ NHEJ v"

(* Explanation 4: The inhibition of PARP by PARP inhibitors directly leads to the occurrence of double-strand breaks and prevents single-strand break repair, which contributes to defective homologous recombination repair. *)
axiomatization where
  explanation_4: "∃x y z w v e1 e2 e3. InhibitionOfPARP x ∧ PARPInhibitors y ∧ DSBs z ∧ SSBreakRepair w ∧ Lead e1 ∧ Agent e1 x ∧ To e1 z ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 w ∧ Contribute e3 ∧ Agent e3 x ∧ Patient e3 v ∧ HRR v"

(* Explanation 5: The inhibition of PARP by PARP inhibitors directly causes double-strand breaks, which leads to reliance on error-prone non-homologous end joining for DNA repair. *)
axiomatization where
  explanation_5: "∃x y z v e1 e2. InhibitionOfPARP x ∧ PARPInhibitors y ∧ DSBs z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 z ∧ Lead e2 ∧ Agent e2 x ∧ RelianceOn e2 v ∧ NHEJ v"

theorem hypothesis:
  assumes asm: "PARPInhibitors x"
  (* Hypothesis: PARP inhibitors cause replication‐associated DSBs by preventing SS break repair, relying on defective HRR and error prone NHEJ to repair DNA. *)
  shows "∃x y z e1 e2 e3. PARPInhibitors x ∧ DSBs y ∧ SSBreakRepair z ∧ Cause e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Prevent e2 ∧ Agent e2 x ∧ Patient e2 z ∧ Rely e3 ∧ Agent e3 x ∧ On e3 HRR ∧ On e3 NHEJ"
  sledgehammer
  oops

end
